Display options
Cite
Okada T, Yamakawa M, Ohmori N, et al. The development of a knowledge base for basic active structures: an example case of dopamine agonists. Chem Cent J. 2010;4(1):1doi: 10.1186/1752-153X-4-1.
Okada, T., Yamakawa, M., Ohmori, N., Mori, S., Horikawa, H., Hayashi, T., & Fujishima, S. (2010). The development of a knowledge base for basic active structures: an example case of dopamine agonists. Chemistry Central journal, 4(1), 1. https://doi.org/10.1186/1752-153X-4-1
Okada, Takashi, et al. "The development of a knowledge base for basic active structures: an example case of dopamine agonists." Chemistry Central journal vol. 4,1 (2010): 1. doi: https://doi.org/10.1186/1752-153X-4-1
Okada T, Yamakawa M, Ohmori N, Mori S, Horikawa H, Hayashi T, Fujishima S. The development of a knowledge base for basic active structures: an example case of dopamine agonists. Chem Cent J. 2010 Jan 23;4(1):1. doi: 10.1186/1752-153X-4-1. PMID: 20181001; PMCID: PMC2829562.
Copy Download .nbib Format: NLM
Share it on

Chem Cent J. 2010 Jan 23;4(1):1. doi: 10.1186/1752-153X-4-1.

The development of a knowledge base for basic active structures: an example case of dopamine agonists.

Chemistry Central journal

Takashi Okada, Masumi Yamakawa, Norihito Ohmori, Sachio Mori, Hiroshi Horikawa, Taketo Hayashi, Satoshi Fujishima

Affiliations

  1. Department of Informatics, School of Science & Technology, Kwansei Gakuin University, Sanda, Hyogo, Japan. [email protected]

PMID: 20181001 PMCID: PMC2829562 DOI: 10.1186/1752-153X-4-1

Abstract

BACKGROUND: Chemical compounds affecting a bioactivity can usually be classified into several groups, each of which shares a characteristic substructure. We call these substructures "basic active structures" or BASs. The extraction of BASs is challenging when the database of compounds contains a variety of skeletons. Data mining technology, associated with the work of chemists, has enabled the systematic elaboration of BASs.

RESULTS: This paper presents a BAS knowledge base, BASiC, which currently covers 46 activities and is available on the Internet. We use the dopamine agonists D1, D2, and Dauto as examples and illustrate the process of BAS extraction. The resulting BASs were reasonably interpreted after proposing a few template structures.

CONCLUSIONS: The knowledge base is useful for drug design. Proposed BASs and their supporting structures in the knowledge base will facilitate the development of new template structures for other activities, and will be useful in the design of new lead compounds via reasonable interpretations of active structures.

References

  1. Drug Discov Today. 2006 Aug;11(15-16):694-9 - PubMed
  2. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):438-42 - PubMed
  3. J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):2145-56 - PubMed
  4. J Chem Inf Model. 2006 Nov-Dec;46(6):2220-9 - PubMed
  5. J Chem Inf Model. 2005 Jul-Aug;45(4):807-15 - PubMed
  6. J Chem Inf Model. 2008 Nov;48(11):2097-107 - PubMed
  7. J Chem Inf Model. 2006 Nov-Dec;46(6):2432-44 - PubMed
  8. Chem Biol Drug Des. 2006 Jun;67(6):395-408 - PubMed
  9. BMC Pharmacol. 2002 Apr 02;2:8 - PubMed
  10. Prog Drug Res. 1993;41:313-57 - PubMed
  11. J Chem Inf Model. 2008 May;48(5):949-57 - PubMed

Publication Types